全文获取类型
收费全文 | 9352篇 |
免费 | 468篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 157篇 |
妇产科学 | 228篇 |
基础医学 | 1067篇 |
口腔科学 | 254篇 |
临床医学 | 648篇 |
内科学 | 2548篇 |
皮肤病学 | 220篇 |
神经病学 | 700篇 |
特种医学 | 344篇 |
外国民族医学 | 2篇 |
外科学 | 1521篇 |
综合类 | 57篇 |
预防医学 | 357篇 |
眼科学 | 164篇 |
药学 | 645篇 |
中国医学 | 8篇 |
肿瘤学 | 868篇 |
出版年
2023年 | 41篇 |
2022年 | 108篇 |
2021年 | 168篇 |
2020年 | 91篇 |
2019年 | 112篇 |
2018年 | 161篇 |
2017年 | 112篇 |
2016年 | 130篇 |
2015年 | 150篇 |
2014年 | 169篇 |
2013年 | 246篇 |
2012年 | 369篇 |
2011年 | 404篇 |
2010年 | 215篇 |
2009年 | 188篇 |
2008年 | 397篇 |
2007年 | 364篇 |
2006年 | 366篇 |
2005年 | 427篇 |
2004年 | 374篇 |
2003年 | 350篇 |
2002年 | 336篇 |
2001年 | 370篇 |
2000年 | 362篇 |
1999年 | 366篇 |
1998年 | 125篇 |
1997年 | 111篇 |
1996年 | 81篇 |
1995年 | 89篇 |
1994年 | 72篇 |
1993年 | 60篇 |
1992年 | 307篇 |
1991年 | 268篇 |
1990年 | 261篇 |
1989年 | 299篇 |
1988年 | 242篇 |
1987年 | 223篇 |
1986年 | 219篇 |
1985年 | 175篇 |
1984年 | 124篇 |
1983年 | 85篇 |
1979年 | 78篇 |
1978年 | 50篇 |
1977年 | 45篇 |
1975年 | 46篇 |
1974年 | 62篇 |
1973年 | 63篇 |
1972年 | 48篇 |
1971年 | 40篇 |
1969年 | 47篇 |
排序方式: 共有9869条查询结果,搜索用时 31 毫秒
991.
992.
Incidence of cerebral palsy in Himeji City in 1983-1997 总被引:1,自引:0,他引:1
Koterazawa K Nakano K Nabetani M Miyata H Kodama S Takada S Nakamura H 《No to hattatsu. Brain and development》2007,39(1):32-36
We retrospectively investigated the incidence, neuroimaging findings, and motor and intellectual disability of infants with cerebral palsy (CP) who were born between 1983 and 1997. The incidence of CP was found to have increased gradually and the major cause was periventricular leukomalacia. The prognosis of preterm infants was better than that of term infants. These findings suggest that the increase in the incidence of CP has been due mainly to changes in medical care for neonates. 相似文献
993.
Yoshimura R Hori H Sugita A Ueda N Kakihara S Umene W Nakano Y Shinkai K Mitoma M Ohta M Shinkai T Nakamura J 《Progress in neuro-psychopharmacology & biological psychiatry》2007,31(5):1072-1077
In the present study, we investigated the effects of risperidone treatment for 4 weeks on plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and brain-derived neurotrophic factor (BDNF) in 89 schizophrenic patients. We also compared the plasma levels of BDNF and MHPG between the schizophrenic group and 103 sex-and age-matched normal controls. In addition, we investigated the effects of two SNPs of the noradrenaline transporter (NAT) gene on plasma levels of MHPG, BDNF, and clinical improvement. The mean dose of risperidone was 3.8+/-1.4 mg/day. We demonstrated that treatment with risperidone increased plasma MHPG levels, and this increase was associated with an improvement of the negative symptoms of schizophrenia. In contrast, plasma BDNF did not change after 4 weeks of risperidone treatment, and the two SNPs in NAT did not influence the response to risperidone treatment or plasma MHPG and BDNF levels. These results suggest that the enhancement of noradrenergic neurons by risperidone, which occurs independently of the two SNPs of NAT, plays a role in the clinical efficacy of the drug. 相似文献
994.
Katano Y Hayashi K Ishigami M Itoh A Hirooka Y Nakano I Goto H 《Hepato-gastroenterology》2007,54(75):854-857
BACKGROUND/AIMS: The 5'-untranslated region (5'UTR) of hepatitis C virus (HCV) is a useful region for determinations of genotype and viral load. 5'UTR can be used for simultaneous analysis of HCV genotype and viral load, therefore several assays have been described. A method which used direct sequencing of the 5'UTR can also be used to identify mutations in this region. The objective of the present study was to evaluate possible associations of 5'UTR mutations with responsiveness to interferon (IFN) therapy in chronic hepatitis C patients. METHODOLOGY: Seventy patients with chronic hepatitis C were included in this study. The relations between responsiveness to IFN therapy and HCV genotype, viral load, and 5'UTR mutations before IFN treatment were evaluated. RESULTS: We detected HCV genotype 1a (n = 5), 1b (n = 32), 2a (n = 15), 2b (n = 12), and 3a (n = 6). Forty-eight patients were non-sustained responders (NR). Seven of 37 (18.9%) patients with the 1a or 1b genotype were sustained responders (SR), and 14 of 27 (51.9%) patients with genotype 2a or 2b were SR. Responses of patients with genotype 1 were poorer than those of patients with genotype 2. HCV viral loads of all SR patients infected with genotype la or 1b were less than 100 KIU/mL, but more than 50% of SR patients infected with genotype 2a or 2b had viral loads over 100 KIU/mL. Thus, viral load in patients with genotype 1 is strongly associated with IFN sensitivity. 5'UTR were well conserved, and there were no differences in the distribution of genotypes between SR and NR. CONCLUSIONS: The 5'UTR is a suitable region for determining HCV genotype and viral load, which are predictors of responsiveness to IFN therapy, but specific mutations of the 5'UTR do not appear to be associated with responsiveness to IFN. 相似文献
995.
Sugawara T Ohkusa Y Taya K Oikawa K Haneda N Kikuchi K Kato F Yamaguchi S Yoshikawa T Nakano T Ihara T Tutumi H Asano Y Kamiya H Okabe N 《Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases》2007,81(5):555-561
OBJECTIVE: Mumps immunization is not included in routine immunization in Japan. We measured the cost-effectiveness of routine immunization. METHODS: We surveyed outpatients prospectively from June 15, 2004, for 19 months in an area with a population of 100,000. Almost all of the 11 pediatric clinics and hospitals in this area cooperated. In 2006, we retrospectively surveyed all inpatients hospitalized for more than 24 hours and dying of mumps. RESULTS: We collected data from 189 doctors who rated outpatients and 112 families. The disease burden for outpatients including family nursing was estimated to be 47.1 billion yen nationwide. We estimated the total number of inpatients as 4,596. The disease burden of inpatients including the cost of family nursing was estimated to be 1.35 billion yen. Adding cases of sequelae and death, the total disease burden was estimated to be 52.5 billion yen. The incremental benefit cost ratio for routine immunization is higher than 1 even in the lower bounds of the 95% confidence interval. DISCUSSION AND CONCLUSIONS: The incremental benefit cost ratio shows that the additional benefit due to routine immunization exceeds additional cost, emphasizing the benefits of routine mumps immunization. 相似文献
996.
997.
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation 总被引:5,自引:0,他引:5
Chiba T Zheng YW Kita K Yokosuka O Saisho H Onodera M Miyoshi H Nakano M Zen Y Nakanuma Y Nakauchi H Iwama A Taniguchi H 《Gastroenterology》2007,133(3):937-950
BACKGROUND & AIMS: Transformed hematopoietic stem/progenitor cells with an enhanced or acquired self-renewal capability function as leukemic stem cells. In a variety of solid cancers, stem/progenitor cells could be also targets of carcinogenesis. However, it remains unclear whether disruption of stem cell function directly contributes to cancer initiation. We sought to elucidate the mechanisms of self-renewal in hepatic stem/progenitor cells and the relation between stem cell function and hepatocarcinogenesis. METHODS: Functional analyses of polycomb-group protein Bmi1 and Wnt/beta-catenin, the molecules that are responsible for the self-renewal capability of many types of stem cells, were conducted in c-Kit(-)CD29(+)CD49f(+/low)CD45(-)Ter-119(-) hepatic stem/progenitor cells using retrovirus- or lentivirus-mediated gene transfer. The tumorigenicity of these cells transduced with the indicated retroviruses was also assessed by transplantation into nonobese diabetic/severe combined immunodeficient mice. RESULTS: Forced expression of Bmi1 and constitutively active beta-catenin mutant similarly promoted the self-renewal of hepatic stem/progenitor cells. The transplantation of Bmi1- or beta-catenin-transduced cells clonally expanded from single hepatic stem/progenitor cells produced tumors, which exhibited the histologic features of combined hepatocellular and cholangiocarcinoma. CONCLUSIONS: These observations imply that the dysregulated self-renewal of hepatic stem/progenitor cells serves as an early event in hepatocarcinogenesis, and they highlight the important roles of Bmi1 and the Wnt/beta-catenin pathway in regulating the self-renewal of normal or cancer stem cells in liver. 相似文献
998.
999.
1000.
Promoter hypomethylation of protease-activated receptor 2 associated with carcinogenesis in the stomach 总被引:2,自引:0,他引:2
Arisawa T Tahara T Shibata T Nagasaka M Nakamura M Kamiya Y Fujita H Takagi T Hasegawa S Wang FY Hirata I Nakano H 《Journal of gastroenterology and hepatology》2007,22(6):943-948
BACKGROUND AND AIM: Trypsin acting at protease-activated receptor 2 (PAR2) contributes to a progression of malignant tumors. An abnormal DNA methylation has been recognized as an important molecular mechanism for the genesis of various types of cancers. We attempted to clarify the relationship between the promoter methylation of PAR2 and gastric cancer. METHOD: We estimated the methylation of the PAR2 promoter in both antral non-cancerous mucosa and cancer lesions in 94 patients with gastric cancer. We employed a methylation-specific PCR method. RESULTS: Regarding the methylation ratio (MR) of antral-non-cancerous mucosa, no significant difference was despite among gender, age and Helicobacter pylori infection status, whereas MR increased rising inflammation scores. The MR of cancer lesions was significantly lower than that of antral non-cancerous mucosa. This finding was not dependent on tumor staging, but also histological classification. In venous invasion, lymph node metastasis, or peritoneal dissemination negative cases, this significant lower MR was also seen. CONCLUSION: The promoter methylation of PAR2 seems to be increased with a progression of chronic inflammation and has an inhibitory effect on carcinogenesis of the stomach. 相似文献